Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Marketwired
377 Leser
Artikel bewerten:
(0)

Federal Home Loan Mortgage Corporation: Freddie Mac Prices $239 Million Multifamily K-Deal, K-J19

Finanznachrichten News

MCLEAN, VA -- (Marketwired) -- 03/28/18 -- Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates) that are backed by underlying collateral consisting of supplemental multifamily mortgages. The company expects to issue approximately $239 million in K Certificates (K-J19 Certificates), which settled on March 27, 2018.

K-J19 Pricing

----------------------------------------------------------------------------
                           Weighted
      Principal/Notional Average Life                               Dollar
Class     Amount (mm)       (Years)   Spread (bps) Coupon   Yield    Price
----------------------------------------------------------------------------
 A-FL   $122,297,000.00      4.85        L + 23    1.9001% 1.9076% $100.0000
----------------------------------------------------------------------------
 A-1    $45,782,000.00       3.50        S + 17    2.9110% 2.8696% $99.9999
----------------------------------------------------------------------------
 A-2    $71,894,000.00       4.56        S + 25    3.4980% 2.9921% $101.9993
----------------------------------------------------------------------------
  XI    $143,879,582.00      4.88                  Non-Offered
----------------------------------------------------------------------------
  XP    $143,879,582.00      4.86                  Non-Offered
----------------------------------------------------------------------------
  X     $147,095,595.00      4.15                  Non-Offered
----------------------------------------------------------------------------

  • Lead Manager and Sole Bookrunner: Merrill Lynch, Pierce, Fenner & Smith Incorporated
  • Co-Managers: Amherst Pierpont Securities LLC, Citigroup Global Markets Inc., KGS-Alpha Capital Markets, L.P. and The Williams Capital Group, L.P.

Related Links

  • The K-J19 Offering Circular Supplement:
    http://www.freddiemac.com/mbs/data/kj19oc.pdf [pdf]
  • Freddie Mac Multifamily Investor Presentation [pdf]
  • Multifamily Securities Investor Access database of post-securitization data from Investor Reporting Packages

The K-J19 Certificates are backed by corresponding classes issued by the FREMF 2018-KJ19 Mortgage Trust (KJ19 Trust) and guaranteed by Freddie Mac. The KJ19 Trust will also issue certificates consisting of class B-FL, class B-FX and class R certificates, which will not be guaranteed by Freddie Mac and will not back any class of K-J19 Certificates.

Freddie Mac Multifamily is a leading issuer of agency-guaranteed structured multifamily securities. K-Deals are part of the company's business strategy to transfer a portion of the risk of losses away from taxpayers and to private investors who purchase the unguaranteed subordinate bonds. K Certificates typically feature a wide range of investor options with stable cash flows and structured credit enhancement.

This announcement is not an offer to sell any Freddie Mac securities. Offers for any given security are made only through applicable offering circulars and related supplements, which incorporate Freddie Mac's Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission (SEC) on February 15, 2018; all other reports Freddie Mac filed with the SEC pursuant to Section 13(a) of the Securities Exchange Act of 1934 (Exchange Act) since December 31, 2017, excluding any information "furnished" to the SEC on Form 8-K; and all documents that Freddie Mac files with the SEC pursuant to Sections 13(a), 13(c) or 14 of the Exchange Act, excluding any information "furnished" to the SEC on Form 8-K.

Freddie Mac's press releases sometimes contain forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond the company's control. Management's expectations for the company's future necessarily involve a number of assumptions, judgments and estimates, and various factors could cause actual results to differ materially from the expectations expressed in these and other forward-looking statements. These assumptions, judgments, estimates and factors are discussed in the company's Annual Report on Form 10-K for the year ended December 31, 2017, and its reports on Form 10-Q and Form 8-K, which are available on the Investor Relations page of the company's Web site at www.FreddieMac.com/investors and the SEC's website at www.sec.gov. The company undertakes no obligation to update forward-looking statements it makes to reflect events or circumstances occurring after the date of this press release.

The financial and other information contained in the documents that may be accessed on this page speaks only as of the date of those documents. The information could be out of date and no longer accurate. Freddie Mac undertakes no obligation, and disclaims any duty, to update any of the information in those documents.

Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we've made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac and Freddie Mac's blog FreddieMac.com/blog.

MEDIA CONTACT:
Christopher Spina
703-388-7031
Christopher_Spina@FreddieMac.com


INVESTOR CONTACT:
Robert Koontz
571-382-4082
Aaron Dunn
571-382-5818


© 2018 Marketwired
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.